Differential Artery-Vein Analysis Improves the Performance of OCTA Staging of Sickle Cell Retinopathy

动脉-静脉差异分析可提高镰状细胞视网膜病变OCTA分期的性能

阅读:1

Abstract

PURPOSE: We test if differential artery-vein analysis can increase the performance of optical coherence tomography angiography (OCTA) detection and classification of sickle cell retinopathy (SCR). METHOD: This observational case series was conducted in a tertiary-retina practice. Color fundus and OCTA images were collected from 20 control and 48 SCR subjects. Fundus data were collected from fundus imaging devices, and SD-OCT and corresponding OCTA data were acquired using a spectral-domain OCT (SD-OCT) angiography system. For each patient, color fundus image-guided artery-vein classification was conducted in the OCTA image. Traditional mean blood vessel tortuosity (m-BVT) and mean blood vessel caliber (m-BVC) in OCTA images were quantified for control and SCR groups. Artery BVC (a-BVC), vein BVC (v-BVC), artery BVT (a-BVT), and vein BVT (v-BVT) were calculated; and then the artery-vein ratio of BVC (AVR-BVC) and artery-vein ratio of BVT (AVR-BVT) were quantified for comparative analysis. RESULTS: We evaluated 40 control and 85 SCR images in this study. The color fundus image-guided artery-vein classification had 97.02% accuracy for differentiating arteries and veins in OCTA. Differential artery-vein analysis provided significant improvement (P < 0.05) in detecting and classifying SCR stages compared to traditional mean blood vessel analysis. AVR-BVT and AVR-BVC showed significant (P < 0.001) correlation with SCR severity. CONCLUSIONS: Differential artery-vein analysis can significantly improve the performance of OCTA detection and classification of SCR. AVR-BVT is the most sensitive feature that can classify control and mild SCR. TRANSLATIONAL RELEVANCE: SCR and other retinovascular diseases result in changes to the caliber and tortuosity appearance of arteries and veins separately. Differential artery-vein analysis can improve the performance of SCR detection and stage classification.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。